latest news releases from the newsroom
Samaritan Pharmaceuticals, Inc.
Samaritan CEO to Speak On Pharma Partnering Panel At 7th Annual Biotech in Europe Investor Forum
LAS VEGAS, Oct. 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs announced today its CEO, Dr. Janet Greeson, has been invited to speak on a pharma partnering panel October 3rd, 9:15 AM at the 7th Annual Biotech in Europe Investor Forum, October 2-3, 2007 in Zurich, Switzerland.
Morris, Manning & Martin, LLP
Patent Law Changes Create 'Land Mines' for Entrepreneurs, Morris, Manning & Martin Attorneys Say
ATLANTA, Oct. 1, 2007 (PRIME NEWSWIRE) -- Recent developments in Washington have created "land mines" which make it more difficult and expensive for entrepreneurs, small businesses, and individual inventors to patent technology, say attorneys at Morris, Manning & Martin, LLP.
Board Evaluations Emerging in More Boardrooms, PricewaterhouseCoopers/Corporate Board Member 2007 Survey Finds
NEW YORK, Oct. 1, 2007 (PRIME NEWSWIRE) -- "What Directors Think," a survey conducted by Corporate Board Member magazine and PricewaterhouseCoopers LLP, found 79 percent of directors believe an effective board evaluation process is the most important technique they use in ensuring that directors continue to be successful on their boards. Further, 88 percent of boards report the entire board's performance is evaluated on a regular basis. This is a significant increase from the 2002 survey, where only 33 percent reported conducting board evaluations.